文献速递前列腺增生与排尿功能障碍

无张力阴道吊带术与聚丙烯酰胺水凝胶注射治疗原发性压力性尿失禁:随机临床试验3年随访

Tension-Free Vaginal Tape and Polyacrylamide Hydrogel Injection for Primary Stress Urinary Incontinence: 3-Year Followup from a Randomized Clinical Trial.
PubMed 文献 · J Urol · 2022-08-05

这项非劣效性随机试验将223例适合手术的原发性压力性尿失禁女性随机分至无张力阴道吊带术(TVT)组110例或聚丙烯酰胺水凝胶(PAHG)组113例,主要结局为患者满意度,非劣效界值20%。3年随访时PAHG未达到研究设定的非劣效标准。

要点

  • 3年时TVT组满意度评分≥80者87例(94.6%),PAHG组65例(67.7%),差异26.9%(95%CI 16.7%至36.8%)。
  • 咳嗽压力试验阴性TVT组88例(95.7%)vs PAHG组75例(78.1%),差异17.5%(95%CI 8.6%至26.9%)。
  • TVT组并发症40例(43.5%)vs PAHG组23例(24.0%),差异19.5%(95%CI 6.8%至31.4%)。

核心结论

  • 中期随访中PAHG在患者满意度方面未达到研究设定的非劣效标准。
  • TVT吊带的主观和客观治愈率优于PAHG,但并发症更多与TVT相关。
  • 由于多数接受PAHG治疗的女性也获得治愈或改善,原发性压力性尿失禁女性可接受PAHG作为安全持久的替代治疗。

研究设计与样本

  • 非劣效性随机临床试验,223例适合手术的压力性尿失禁女性随机分为TVT组110例和PAHG组113例。
  • 主要结局为患者满意度,非劣效界值为20%;次要结局为有效性和并发症。

主要发现

  • 3年时188例(84.3%)女性完成随访。
  • 满意度评分(视觉模拟量表0-100)中位数TVT组98.5(IQR 90-100)vs PAHG组90.0(IQR 70-100)。
  • 满意度评分≥80者TVT组87例(94.6%)vs PAHG组65例(67.7%),差异26.9%(95%CI 16.7%至36.8%)。
  • 咳嗽压力试验阴性TVT组88例(95.7%)vs PAHG组75例(78.1%),差异17.5%(95%CI 8.6%至26.9%)。
  • 交叉前任何围手术期或术后并发症TVT组40例(43.5%)vs PAHG组23例(24.0%),差异19.5%(95%CI 6.8%至31.4%)。

关键数值与推荐

  • PAHG未达到研究设定的患者满意度非劣效标准。
  • TVT组满意度评分≥80比例高于PAHG组,差异26.9%(95%CI 16.7%至36.8%)。
  • TVT组咳嗽压力试验阴性率高于PAHG组,差异17.5%(95%CI 8.6%至26.9%)。
  • TVT组并发症发生率高于PAHG组,差异19.5%(95%CI 6.8%至31.4%)。

临床怎么用

  • 作者认为,由于多数接受PAHG治疗的女性也获得治愈或改善,原发性压力性尿失禁女性可接受PAHG作为安全持久的替代治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to determine whether polyacrylamide hydrogel (PAHG) is noninferior to tension-free vaginal tape (TVT) in the treatment of women with primary stress urinary incontinence (SUI). MATERIALS AND METHODS: In this noninferiority trial, 223 women eligible for operative SUI treatment were randomized for TVT (110) or PAHG (113). Primary outcome was patient satisfaction and the noninferiority margin for the difference was 20%. Secondary outcomes were effectiveness and complications. RESULTS: At 3 years, 188 (84.3%) women attended the followup. The satisfaction score (visual analogue scale 0-100) median was 98.5 (IQR 90-100) in the TVT group and 90.0 (IQR 70-100) in the PAHG group, whereas a score ≥80 was reached in 87 (94.6%) and 65 (67.7%), respectively (difference 26.9%, 95% CI 16.7% to 36.8%). Thus, PAHG did not meet the noninferiority criteria set in our study. The cough stress test was negative in 88 (95.7%) of TVT patients vs 75 (78.1%) of PAHG patients (difference 17.5%, 95% CI 8.6% to 26.9%). Any peri- or postoperative complication before crossover between the groups was detected in 40 (43.5%) women in the TVT group and 23 (24.0%) women in the PAHG group (difference 19.5%, 95% CI 6.8% to 31.4%). CONCLUSIONS: In midterm followup, PAHG did not reach in patient satisfaction the noninferiority set in our study. Furthermore, mid urethral TVT slings show better subjective and objective cure rates than PAHG. However, complications were more often associated with TVT. Since the majority of PAHG treated women were also cured or improved, primary SUI women can be offered PAHG as a safe and durable alternative treatment.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Itkonen Freitas AM, Isaksson C, Rahkola-Soisalo P, et al. Tension-Free Vaginal Tape and Polyacrylamide Hydrogel Injection for Primary Stress Urinary Incontinence: 3-Year Followup from a Randomized Clinical Trial. J Urol. 2022. PMID: 35942796. doi:10.1097/JU.0000000000002720

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。